What is Coherence Neuro?
Coherence Neuro is a pioneering medical technology firm operating at the confluence of neurotechnology, neurobiology, and machine learning. The company's core mission is to enhance both the quality and longevity of life for individuals battling cancer. Challenging the traditional, often harsh methods of cutting, burning, or poisoning cancer, Coherence Neuro is spearheading a paradigm shift. They aim to transform cancer treatment from a severe confrontation into a meticulously managed condition by leveraging advanced technology and groundbreaking research.
How much funding has Coherence Neuro raised?
Coherence Neuro has raised a total of $10M across 1 funding round:
Seed
$10M
Seed (2025): $10M with participation from Artesian, XTAL Strategies, SmartGateVC, Blackbird Ventures, and Possible Ventures
Key Investors in Coherence Neuro
Artesian
Artesian is an investment firm known for backing innovative companies, likely focusing on technology and growth-stage ventures.
XTAL Strategies
XTAL Strategies appears to be a strategic investment group, potentially focused on companies with disruptive technologies or market-changing potential.
SmartGateVC
SmartGateVC is an early-stage venture capital firm that invests in technology startups, suggesting a focus on innovative and scalable solutions.
What's next for Coherence Neuro?
The recent major strategic investment and enterprise-level funding context suggest Coherence Neuro is in a crucial scaling phase, likely moving beyond initial development and into broader clinical application and market penetration. This capital infusion is expected to accelerate the company's research and development efforts, potentially enabling further clinical trials, expanding its technological infrastructure, and forging strategic partnerships. The focus on transforming cancer treatment indicates a long-term vision for significant market disruption and impact on patient outcomes.
See full Coherence Neuro company page
